Effects of Hydrotherapy During Post-COVID-19 Rehabilitation
Effects of Kneipp Hydrotherapy During Inpatient Post-Covid-19 Rehabilitation: A Randomized Controlled Trial
Schön Klinik Berchtesgadener Land
50 participants
Aug 21, 2025
INTERVENTIONAL
Conditions
Summary
This randomized controlled study evaluates the effects of cold water hydrotherapy as an adjunct to standard rehabilitation in patients with Post-COVID Syndrome. The primary aim is to assess changes in quality of life compared to standard rehabilitation alone.
Eligibility
Inclusion Criteria5
- Diagnosis of Post-COVID Syndrome (ICD-10 code: U08.9)
- Barthel-Index >80
- Referred to the reference center for Post-COVID rehabilitation
- Owning a smartphone to receive digital questionnaires and to use the measurement app for heart rate variability
- Written informed consent
Exclusion Criteria2
- Existing contraindications for Kneipp hydrotherapy like severe cardiovascular diseases (e.g., decompensated heart failure, unstable angina pectoris, acute myocardial infarction), severe venous diseases (e.g., acute deep vein thrombosis of the leg), severe neurological diseases (e.g., uncontrolled epilepsy)
- Prior regular practice of Kneipp applications
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Cold water hydrotherapy (5-10 minutes each), twice daily during the 3-week multimodal inpatient rehabilitation program and once daily during the 6-month follow-up period
same rehabilitation program than the experimental group but without hydrotherapy
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07013903